Katja Witschas

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Acta physiologica (Oxford, England)

International journal of molecular sciences

The Journal of physiology

British journal of pharmacology

Ghent University

University of Cologne (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ghent University Nov 01 2018

Belgium

Postdoctoral Research Assistant :: Department of Basic and Applied Medical Sciences, Physiology group

University of Oxford May 01 2017 - Apr 30 2018

United Kingdom

Visiting Research Scientist :: Department of Pharmacology

University of Oxford Apr 15 2014 - Apr 15 2017

United Kingdom

Postdoctoral Research Assistant :: Department of Pharmacology

Academy of Sciences of the Czech Republic Sep 01 2012 - Oct 31 2013

Czechia

Postdoctoral Researcher :: Department of Cellular Neurophysiology

University of Bordeaux Aug 15 2013 - Oct 15 2013

France

Visiting Research Scientist :: Chimie et Biologie des Membranes et des Nanoobjects

RWTH Aachen University May 01 2007 - Aug 31 2012

Germany

PhD student :: Institute of Physiology

Education History

University of Cologne

Germany

MSC

Publications

Siyu Tao, Paco Hulpiau, Larry E Wagner, Katja Witschas, David I Yule, Geert Bultynck, Luc Leybaert
IP3RPEP6, a novel peptide inhibitor of IP 3 receptor channels that does not affect connexin-43 hemichannels. Acta physiologica (Oxford, England) 240 (3) (2024)
Siyu Tao, Paco Hulpiau, Larry E Wagner, Katja Witschas, David I Yule, Geert Bultynck, Luc Leybaert
IP3RPEP6, a novel peptide inhibitor of IP 3 receptor channels that does not affect connexin-43 hemichannels. Acta physiologica (Oxford, England) (2024)
Siyu Tao, Paco Hulpiau, Larry E Wagner, Katja Witschas, David I Yule, Geert Bultynck, Luc Leybaert
IP3RPEP6, a novel peptide inhibitor of IP 3 receptor channels that does not affect connexin-43 hemichannels. Acta physiologica (Oxford, England) 240 (3) (2024)
Siyu Tao, Paco Hulpiau, Larry E Wagner, Katja Witschas, David I Yule, Geert Bultynck, Luc Leybaert
IP3RPEP6, a novel peptide inhibitor of IP 3 receptor channels that does not affect connexin-43 hemichannels. Acta physiologica (Oxford, England) 240 (3) (2024)
Alessio Lissoni, Siyu Tao, Rosalie Allewaert, Katja Witschas, Luc Leybaert
Cx43 Hemichannel and Panx1 Channel Modulation by Gap19 and 10 Panx1 Peptides. International journal of molecular sciences 24 (14) (2023)
Steffi Schumacher, Hanane Tahiri, Pascal Ezan, Nathalie Rouach, Katja Witschas, Luc Leybaert
Inhibiting astrocyte connexin-43 hemichannels blocks radiation-induced vesicular VEGF-A release and blood-brain barrier dysfunction. Glia (2023)
Alessio Lissoni, Nan Wang, Timur Nezlobinskii, Maarten A J De Smet, Alexander V Panfilov, Nele Vandersickel, Luc Leybaert, Katja Witschas
Gap19, a Cx43 Hemichannel Inhibitor, Acts as a Gating Modifier That Decreases Main State Opening While Increasing Substate Gating. International journal of molecular sciences 21 (19) (2020)
Fiona O'Brien, David Eberhardt, Katja Witschas, Sam El-Ajouz, Tsunaki Iida, Miyuki Nishi, Hiroshi Takeshima, Rebecca Sitsapesan, Elisa Venturi
Enhanced activity of multiple TRIC-B channels: an endoplasmic reticulum/sarcoplasmic reticulum mechanism to boost counterion currents. The Journal of physiology 597 (10) (2019)
Elisa Venturi, Chris Lindsay, Sabine Lotteau, Zhaokang Yang, Emma Steer, Katja Witschas, Abigail D Wilson, James R Wickens, Angela J Russell, Derek Steele, Sarah C Calaghan, Rebecca Sitsapesan
Simvastatin activates single skeletal RyR1 channels but exerts more complex regulation of the cardiac RyR2 isoform. British journal of pharmacology 175 (6) (2018)

Katja Witschas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Katja Witschas